A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging
Heeman W, Vonk J, Ntziachristos V, Pogue BW, Dierckx RAJO, Kruijff S, Van Dam GM (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Book Volume: 63
Pages Range: 640-645
Journal Issue: 5
DOI: 10.2967/jnumed.121.262975
Abstract
Fluorescence imaging is an emerging imaging technique that has shown many benefits for clinical care. Currently, the field is in rapid clinical translation, and an unprecedented number of clinical trials are performed. Clinicians are inundated with numerous opportunities and combinations of different imaging modalities. To streamline this process, a multidisciplinary approach is needed with drug discovery, software and systems engineering, and translational medicine. Here, we discuss the main constituents of a uniform fluorescence imaging protocol to match the clinical need and ensure consistent study designs and reliable data collection in clinical trials. In an era in which the potential of fluorescence imaging has become evident, consistent conduct of studies, data analysis, and data interpretation is essential for implementation into the standard of care. COPYRIGHT
Involved external institutions
University of Groningen / Rijksuniversiteit Groningen
Netherlands (NL)
Technische Universität München (TUM)
Germany (DE)
Dartmouth College
United States (USA) (US)
Netherlands (NL)
Technische Universität München (TUM)
Germany (DE)
Dartmouth College
United States (USA) (US)
How to cite
APA:
Heeman, W., Vonk, J., Ntziachristos, V., Pogue, B.W., Dierckx, R.A.J.O., Kruijff, S., & Van Dam, G.M. (2022). A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging. Journal of Nuclear Medicine, 63(5), 640-645. https://doi.org/10.2967/jnumed.121.262975
MLA:
Heeman, Wido, et al. "A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging." Journal of Nuclear Medicine 63.5 (2022): 640-645.
BibTeX: Download